KPC Pharmaceuticals,Inc. (SHA:600422)
China
· Delayed Price · Currency is CNY 9.50
+0.01 (0.11%)
Apr 29, 2026, 3:00 PM CST
KPC Pharmaceuticals,Inc. Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 7,191 | 9,508 | 11,998 | 15,812 | 10,707 | 8,379 | Upgrade
|
| Market Cap Growth | -44.83% | -20.76% | -24.12% | 47.68% | 27.78% | 27.75% | Upgrade
|
| Enterprise Value | 8,759 | 9,988 | 10,979 | 15,195 | 10,654 | 7,992 | Upgrade
|
| Last Close Price | 9.50 | 12.56 | 15.53 | 20.16 | 13.53 | 10.34 | Upgrade
|
| PE Ratio | 61.26 | 27.17 | 18.51 | 29.24 | 27.94 | 16.50 | Upgrade
|
| Forward PE | 22.75 | 13.01 | 18.24 | 23.08 | 17.54 | 13.16 | Upgrade
|
| PS Ratio | 1.24 | 1.45 | 1.43 | 1.88 | 1.29 | 1.01 | Upgrade
|
| PB Ratio | 1.06 | 1.37 | 1.78 | 1.99 | 2.08 | 1.70 | Upgrade
|
| P/TBV Ratio | 2.14 | 2.72 | 3.59 | 3.42 | 2.36 | 1.96 | Upgrade
|
| P/FCF Ratio | - | 47.86 | 16.47 | 24.53 | 70.37 | 542.13 | Upgrade
|
| P/OCF Ratio | - | 32.87 | 14.85 | 20.96 | 42.17 | 33.30 | Upgrade
|
| PEG Ratio | - | 1.18 | 1.18 | 1.18 | 1.18 | 1.18 | Upgrade
|
| EV/Sales Ratio | 1.51 | 1.52 | 1.31 | 1.80 | 1.29 | 0.97 | Upgrade
|
| EV/EBITDA Ratio | 61.36 | 23.36 | 11.08 | 17.43 | 14.32 | 14.07 | Upgrade
|
| EV/EBIT Ratio | - | 37.26 | 13.45 | 21.82 | 18.91 | 19.53 | Upgrade
|
| EV/FCF Ratio | -29.73 | 50.27 | 15.07 | 23.57 | 70.02 | 517.08 | Upgrade
|
| Debt / Equity Ratio | 0.24 | 0.24 | 0.12 | 0.11 | 0.22 | 0.17 | Upgrade
|
| Debt / EBITDA Ratio | 11.32 | 3.71 | 0.82 | 0.99 | 1.48 | 1.40 | Upgrade
|
| Debt / FCF Ratio | - | 8.48 | 1.14 | 1.40 | 7.49 | 53.57 | Upgrade
|
| Net Debt / Equity Ratio | 0.00 | -0.09 | -0.28 | -0.15 | -0.16 | -0.18 | Upgrade
|
| Net Debt / EBITDA Ratio | -0.07 | -1.54 | -1.92 | -1.38 | -1.13 | -1.60 | Upgrade
|
| Net Debt / FCF Ratio | 0.03 | -3.31 | -2.61 | -1.86 | -5.51 | -58.67 | Upgrade
|
| Asset Turnover | 0.49 | 0.54 | 0.68 | 0.78 | 0.90 | 0.97 | Upgrade
|
| Inventory Turnover | 2.37 | 2.78 | 2.88 | 2.63 | 2.72 | 2.70 | Upgrade
|
| Quick Ratio | 1.55 | 1.58 | 1.22 | 1.59 | 1.21 | 1.12 | Upgrade
|
| Current Ratio | 2.09 | 2.02 | 1.56 | 2.11 | 1.74 | 1.77 | Upgrade
|
| Return on Equity (ROE) | 2.35% | 6.12% | 10.22% | 9.81% | 7.65% | 10.76% | Upgrade
|
| Return on Assets (ROA) | -0.21% | 1.37% | 4.10% | 4.01% | 3.84% | 2.99% | Upgrade
|
| Return on Invested Capital (ROIC) | -0.52% | 4.26% | 11.32% | 10.30% | 10.92% | 8.71% | Upgrade
|
| Return on Capital Employed (ROCE) | -0.50% | 3.40% | 11.50% | 8.30% | 10.20% | 7.60% | Upgrade
|
| Earnings Yield | 1.64% | 3.68% | 5.40% | 3.42% | 3.58% | 6.06% | Upgrade
|
| FCF Yield | -4.10% | 2.09% | 6.07% | 4.08% | 1.42% | 0.18% | Upgrade
|
| Dividend Yield | 1.90% | 1.43% | 1.93% | 0.99% | 1.18% | 2.61% | Upgrade
|
| Payout Ratio | 237.17% | 80.03% | 26.62% | 27.11% | 60.37% | 40.10% | Upgrade
|
| Buyback Yield / Dilution | -1.30% | -0.95% | 1.05% | -1.36% | 0.84% | 0.19% | Upgrade
|
| Total Shareholder Return | 0.60% | 0.48% | 2.98% | -0.37% | 2.02% | 2.80% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.